Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 13-Sep-24 8:29 PM View:  | Gaugler Daryl Chief Operating Officer | Pacira Pharmaceuticals, Inc. (PCRX) | 13-Sep-24 | Sale (Planned) | 500 | $12.86 | $6,430.00 | (< 1%) 116.2K to 115.7K | |
| 19-Aug-24 8:25 AM View: | Bigal Marcelo Director | Pacira Pharmaceuticals, Inc. (PCRX) | 16-Aug-24 | Private Purchase | 1,512 | $13.25 | $20,034.00 | 18% 8.63K to 10.14K | |
| 19-Aug-24 8:25 AM View: | Brege Laura Director | Pacira Pharmaceuticals, Inc. (PCRX) | 16-Aug-24 | Private Purchase | 1,000 | $12.81 | $12,810.00 | 6% 16.55K to 17.55K | |
| 14-Aug-24 4:35 PM View: | Yang Michael J. Director | Pacira Pharmaceuticals, Inc. (PCRX) | 14-Aug-24 | Private Purchase | 2,000 | $12.90 | $25,800.00 | 38% 5.23K to 7.23K | |
| 12-Aug-24 8:33 PM View: | Froimson Mark Director | Pacira Pharmaceuticals, Inc. (PCRX) | 12-Aug-24 | Private Purchase | 1,400 | $11.58 | $16,212.00 | 11% 13.07K to 14.47K | |
| 12-Aug-24 8:33 PM View: | Bigal Marcelo Director | Pacira Pharmaceuticals, Inc. (PCRX) | 12-Aug-24 | Private Purchase | 3,400 | $12.01 | $40,834.00 | 65% 5.23K to 8.63K | |
| 13-Aug-24 4:55 PM View: | Lee Frank D. Chief Executive Officer Director | Pacira Pharmaceuticals, Inc. (PCRX) | 12-Aug-24 | Private Purchase | 8,264 | $12.10 | $99,994.40 | 8% 99.52K to 107.78K | |
| 02-Aug-24 6:00 PM View: | Slonin Jonathan Chief Medical Officer | Pacira Pharmaceuticals, Inc. (PCRX) | 02-Aug-24 | Sale (Planned) | 945 | $20.05 | $18,947.20 | (< 1%) 95.25K to 94.31K | |
| 02-Aug-24 6:00 PM View: | Slonin Jonathan Chief Medical Officer | Pacira Pharmaceuticals, Inc. (PCRX) | 01-Aug-24 | Payment of Exercise | 305 | $20.75 | $6,328.75 | (< 1%) 95.56K to 95.25K | |
| 03-Jul-24 6:52 PM View: | Slonin Jonathan Chief Medical Officer | Pacira Pharmaceuticals, Inc. (PCRX) | 02-Jul-24 | Sale (Planned) | 2,836 | $28.25 | $80,117.00 | (3%) 98.39K to 95.56K | |
| 03-Jul-24 6:52 PM View: | Slonin Jonathan Chief Medical Officer | Pacira Pharmaceuticals, Inc. (PCRX) | 01-Jul-24 | Payment of Exercise | 914 | $28.46 | $26,012.40 | (< 1%) 99.31K to 98.39K | |
| 03-Jul-24 6:52 PM View: | Gaugler Daryl Chief Operating Officer | Pacira Pharmaceuticals, Inc. (PCRX) | 28-Jun-24 | Grant | 160 | $24.32 | $3,899.99 | < 1% 116.04K to 116.2K | |
| 03-Jul-24 6:52 PM View: | Slonin Jonathan Chief Medical Officer | Pacira Pharmaceuticals, Inc. (PCRX) | 28-Jun-24 | Grant | 437 | $24.32 | $10,634.00 | < 1% 98.87K to 99.31K | |
| 13-Jun-24 6:13 PM View: | Gaugler Daryl Chief Operating Officer | Pacira Pharmaceuticals, Inc. (PCRX) | 13-Jun-24 | Sale (Planned) | 1,000 | $28.38 | $28,380.00 | (< 1%) 117.04K to 116.04K | |
| 13-Jun-24 6:13 PM View: | Hastings Paul J Director | Pacira Pharmaceuticals, Inc. (PCRX) | 13-Jun-24 | Sale (Planned) | 880 | $28.38 | $24,974.40 | (6%) 13.6K to 12.72K | |
| 13-Jun-24 6:12 PM View: | Dunker Kristen Marie Chief Administrative Officer | Pacira Pharmaceuticals, Inc. (PCRX) | 13-Jun-24 | Sale (Planned) | 7,452 | $28.38 | $211,488.00 | (7%) 110.36K to 102.91K | |
| 13-Jun-24 6:15 PM View: | Riker Lauren Bullaro Senior Vice President, Finance | Pacira Pharmaceuticals, Inc. (PCRX) | 12-Jun-24 | Sale (Planned) | 3,970 | $28.72 | $114,018.00 | (9%) 42.05K to 38.08K | |
| 13-Jun-24 6:12 PM View: | Kronenfeld Mark A. Director | Pacira Pharmaceuticals, Inc. (PCRX) | 12-Jun-24 | Grant | 5,230 | -- | -- | 27% 19.67K to 24.9K | |
| 13-Jun-24 6:13 PM View: | Gaugler Daryl Chief Operating Officer | Pacira Pharmaceuticals, Inc. (PCRX) | 12-Jun-24 | Grant | 54,300 | -- | -- | 87% 62.74K to 117.04K | |
| 13-Jun-24 6:12 PM View: | Dunker Kristen Marie Chief Administrative Officer | Pacira Pharmaceuticals, Inc. (PCRX) | 12-Jun-24 | Grant | 54,300 | -- | -- | 97% 56.06K to 110.36K | |
| 13-Jun-24 6:14 PM View: | Christie Christopher Director | Pacira Pharmaceuticals, Inc. (PCRX) | 12-Jun-24 | Grant | 5,230 | -- | -- | 99% 5.26K to 10.49K | |
| 13-Jun-24 6:15 PM View: | Slonin Jonathan Chief Medical Officer | Pacira Pharmaceuticals, Inc. (PCRX) | 12-Jun-24 | Grant | 54,300 | -- | -- | 122% 44.57K to 98.87K | |
| 13-Jun-24 6:15 PM View: | Riker Lauren Bullaro Senior Vice President, Finance | Pacira Pharmaceuticals, Inc. (PCRX) | 12-Jun-24 | Grant | 21,360 | -- | -- | 103% 20.68K to 42.05K | |
| 13-Jun-24 6:12 PM View: | Brege Laura Director | Pacira Pharmaceuticals, Inc. (PCRX) | 12-Jun-24 | Grant | 5,230 | -- | -- | 46% 11.32K to 16.55K | |
| 13-Jun-24 6:13 PM View: | Ceesay Abraham Director | Pacira Pharmaceuticals, Inc. (PCRX) | 12-Jun-24 | Grant | 5,230 | -- | -- | 100% 0 to 5.23K | |
| 13-Jun-24 6:13 PM View: | Young Alethia Director | Pacira Pharmaceuticals, Inc. (PCRX) | 12-Jun-24 | Grant | 5,230 | -- | -- | 100% 0 to 5.23K | |
| 13-Jun-24 6:14 PM View: | Reinhart Charles A. III Chief Financial Officer | Pacira Pharmaceuticals, Inc. (PCRX) | 12-Jun-24 | Grant | 12,220 | -- | -- | 31% 39.65K to 51.87K | |
| 13-Jun-24 6:13 PM View: | Froimson Mark Director | Pacira Pharmaceuticals, Inc. (PCRX) | 12-Jun-24 | Grant | 5,230 | -- | -- | 67% 7.84K to 13.07K | |
| 13-Jun-24 6:14 PM View: | Bigal Marcelo Director | Pacira Pharmaceuticals, Inc. (PCRX) | 12-Jun-24 | Grant | 5,230 | -- | -- | 100% 0 to 5.23K | |
| 13-Jun-24 6:13 PM View: | Yang Michael J. Director | Pacira Pharmaceuticals, Inc. (PCRX) | 12-Jun-24 | Grant | 5,230 | -- | -- | 100% 0 to 5.23K | |
| 13-Jun-24 6:13 PM View: | Hastings Paul J Director | Pacira Pharmaceuticals, Inc. (PCRX) | 12-Jun-24 | Grant | 5,230 | -- | -- | 62% 8.37K to 13.6K | |
| 13-Jun-24 6:15 PM View: | Slonin Jonathan Chief Medical Officer | Pacira Pharmaceuticals, Inc. (PCRX) | 11-Jun-24 | Sale (Planned) | 5,012 | $28.57 | $143,193.00 | (10%) 49.58K to 44.57K | |
| 05-Jun-24 5:09 PM View: | Slonin Jonathan Chief Medical Officer | Pacira Pharmaceuticals, Inc. (PCRX) | 03-Jun-24 | Payment of Exercise | 1,615 | $30.89 | $49,887.30 | (3%) 51.2K to 49.58K | |
| 05-Jun-24 5:09 PM View: | Reinhart Charles A. III Chief Financial Officer | Pacira Pharmaceuticals, Inc. (PCRX) | 03-Jun-24 | Payment of Exercise | 2,979 | $30.89 | $92,021.30 | (7%) 42.63K to 39.65K | |
| 05-Jun-24 5:09 PM View: | Dunker Kristen Marie Chief Administrative Officer | Pacira Pharmaceuticals, Inc. (PCRX) | 03-Jun-24 | Payment of Exercise | 3,011 | $30.89 | $93,009.80 | (5%) 59.08K to 56.06K | |
| 05-Jun-24 5:10 PM View: | Riker Lauren Bullaro Senior Vice President, Finance | Pacira Pharmaceuticals, Inc. (PCRX) | 03-Jun-24 | Payment of Exercise | 1,843 | $30.89 | $56,930.30 | (8%) 22.53K to 20.68K | |
| 05-Jun-24 5:09 PM View: | Gaugler Daryl Chief Operating Officer | Pacira Pharmaceuticals, Inc. (PCRX) | 03-Jun-24 | Payment of Exercise | 2,754 | $30.89 | $85,071.10 | (4%) 65.49K to 62.74K | |
| 08-Mar-24 5:33 PM View: | Pace Gary W Director | Pacira Pharmaceuticals, Inc. (PCRX) | 08-Mar-24 | Sale | 90,000 | $30.60 | $2,754,000.00 | (80%) 112.13K to 22.13K | |
| 08-Mar-24 5:33 PM View: | Pace Gary W Director | Pacira Pharmaceuticals, Inc. (PCRX) | 07-Mar-24 | Sale | 28,257 | $30.81 | $870,598.00 | (20%) 140.38K to 112.13K | |
| 08-Mar-24 5:33 PM View: | Pace Gary W Director | Pacira Pharmaceuticals, Inc. (PCRX) | 06-Mar-24 | Sale | 1,066 | $29.67 | $31,628.20 | (< 1%) 141.45K to 140.38K | |
| 07-Feb-24 4:59 PM View: | Gaugler Daryl Chief Operating Officer | Pacira Pharmaceuticals, Inc. (PCRX) | 05-Feb-24 | Grant | 33,700 | -- | -- | 106% 31.79K to 65.49K | |
| 07-Feb-24 4:59 PM View: | Dunker Kristen Marie Chief Administrative Officer | Pacira Pharmaceuticals, Inc. (PCRX) | 05-Feb-24 | Grant | 33,700 | -- | -- | 133% 25.38K to 59.08K | |
| 04-Jan-24 5:25 PM View: | Riker Lauren Bullaro Senior Vice President, Finance | Pacira Pharmaceuticals, Inc. (PCRX) | 02-Jan-24 | Payment of Exercise | 159 | $32.00 | $5,088.00 | (< 1%) 22.69K to 22.53K | |
| 04-Jan-24 5:21 PM View: | Lee Frank D. Chief Executive Officer Director | Pacira Pharmaceuticals, Inc. (PCRX) | 02-Jan-24 | Grant | 99,520 | -- | -- | 100% 0 to 99.52K | |
| 04-Jan-24 5:24 PM View: | Slonin Jonathan Chief Medical Officer | Pacira Pharmaceuticals, Inc. (PCRX) | 02-Jan-24 | Grant | 5,000 | -- | -- | 11% 46.2K to 51.2K | |
| 04-Aug-23 4:47 PM View: | Winston Roy Chief Medical Officer | Pacira Pharmaceuticals, Inc. (PCRX) | 02-Aug-23 | Sale | 509 | $34.88 | $17,751.40 | (< 1%) 52.95K to 52.44K | |
| 07-Jul-23 8:04 PM View: | Riker Lauren Bullaro Senior Vice President, Finance | Pacira Pharmaceuticals, Inc. (PCRX) | 05-Jul-23 | Sale (Planned) | 643 | $38.91 | $25,019.10 | (3%) 23.33K to 22.69K | |
| 12-Jun-23 4:16 PM View: | Kronenfeld Mark A. Director | Pacira Pharmaceuticals, Inc. (PCRX) | 08-Jun-23 | Option Exercise | 15,000 | $29.90 | $448,500.00 | 84% 17.9K to 32.9K | |
| 12-Jun-23 4:16 PM View: | Kronenfeld Mark A. Director | Pacira Pharmaceuticals, Inc. (PCRX) | 08-Jun-23 | Planned Option Sale | 15,000 | $37.04 | $555,600.00 | (46%) 32.9K to 17.9K | |
| 07-Jun-23 9:24 PM View: | McLoughlin Dennis Chief Customer Officer | Pacira Pharmaceuticals, Inc. (PCRX) | 07-Jun-23 | Sale | 1,057 | $37.87 | $40,023.30 | (3%) 39.17K to 38.12K |
